Join our daily newsletter At The Bell to receive exclusive market insights
The ASX200 has been up down 0.12% at 8,082 points, even on the back of Wall Street chalking up solid gains on Friday.
Australian second quarter GDP growth figures are out this Wednesday and the consensus forecast is a further slowing in the economy. Meanwhile, a dip in gold prices overnight is hurting Australia’s miners.
The Energy sector has been up point eight of a percent, followed by Financials up point six of a percent. Telecommunication has been heavily sold, down 1.3%, followed by Materials down 1% and Health Care 0.9%.
Company News
Raiden Resources (ASX:RDN) has been up more than 11% after regulators approved a tenement on its Andover South Project in WA. The Diamond drilling program will commence as soon as the Programme of Work is approved.
Raiden Resources has been around 2.9 cents.
Imugene (ASX:IMU) has been up more than 12% after 3 patients responded positively to its latest blood cancer treatment trial with one showing a complete response for over 100 days. Recruitment remains ongoing to test its drug azer-cel in multiple countries.
Imugene has been around 7 cents.
Bellevue Gold (ASX:BGL) has been down more than 7% as investors react to its maiden full year NPAT of $75 million. The results follow first production in October last year and 93.6koz of gold sold in FY24.
Bellevue Gold has been trading at $1.18.
